1. R N Brogden, R C Heel, T M Speight, G S Avery; Piroxicam: a review of its pharmacological properties and therapeutic efficacy; [Revised on Sep 1981] [Accessed 30 Jan 2021] https://pubmed.ncbi.nlm.nih.gov/7021122/
2. R L Wiseman, M Kilgour, Intramuscular piroxicam, a new dosage form, in the treatment of acute musculoskeletal disorders; [Revised on 1985] [Accessed 01 Feb 2021] https://pubmed.ncbi.nlm.nih.gov/2932357/
3. K.D.Tripathi, Essentials of medical pharmacology, AUTACOIDS AND RELATED DRUGS, Chapter 14 NSAIDs AND ANTIPYRETIC-ANALGESICS, 7th edition 2013, Page – 201, 202.
4. Fareva Amboise, Electronic Medicines Compendium (EMC); [Revised on Dec 2020] [Accessed 30 Jan 2021] https://www.medicines.org.uk/emc/files/pil.2902.pdf
5. Accord, Barnstaple; Electronic Medicines Compendium (EMC); [Revised on July 2020] [Accessed 30 Jan 2021] https://www.medicines.org.uk/emc/files/pil.5845.pdf
6. Pfizer Ltd, Feldene products [Revised on 1995] [Accessed 30 Jan 2021] http://mcs.open.ac.uk/nlg/old_projects/pills/corpus/PIL/data/Pfizer/Feldene_Gel/Feldene_Gel.html